Pharmosa Biopharm, Inc. operates as a biotechnology company, which engages in the research, development, and sale of innovative drugs and medical equipment. Its products include metered dose inhalers, soft mist inhalers, and liquid nebulizers. The company was founded on May 25, 2000 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company